Role of heat shock protein 47 in intestinal fibrosis of experimental colitis

Biochemical and Biophysical Research Communications

Volumn 404, Issue 2, 2011, Pages 599-604

  Kitamura, Hiroshi ^a   Yamamoto, Shuji ^a   Nakase, Hiroshi ^a   Matsuura, Minoru ^a   Honzawa, Yusuke ^a   Matsumura, Kayoko ^a   Takeda, Yasuhiro ^a   Uza, Norimitsu ^a   Nagata, Kazuhiro ^b   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Heat shock protein 47; Inflammatory bowel disease; Intestinal fibrosis

Indexed keywords

COLLAGEN; CYTOKINE; HEAT SHOCK PROTEIN 47; INTERLEUKIN 10; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; COLITIS; COLON; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTESTINAL FIBROSIS; MESENCHYME CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STIMULATION; SUBMUCOSA; WILD TYPE;

ANIMALS; COLITIS; COLLAGEN; COLON; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION; HSP47 HEAT-SHOCK PROTEINS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOFIBROBLASTS; NIH 3T3 CELLS; RNA, SMALL INTERFERING;

MURINAE; MUS;

EID: 78651379106     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.006     Document Type: Article

References (25)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205.
2. Rufo P.A., Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr. Drugs 2006, 8:279-302.
3. Rampton D.S. Management of Crohn's disease. BMJ 1999, 319:1480-1485.
4. Froehlich F., Juillerat P., Mottet C., et al. Obstructive fibrostenotic Crohn's disease. Digestion 2005, 71:29-30.
5. Lawrance I.C., Maxwell L., Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm. Bowel Dis. 2001, 7:226-236.
6. Monteleone G., Boirivant M., Pallone F., et al. TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunol. Suppl. 2008, 1:S50-53.
7. Verrecchia F., Mauviel A., Farge D. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis. Autoimmun. Rev. 2006, 5:563-569.
8. Gressner A.M., Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cell Mol. Med. 2006, 10:76-99.
9. Monteleone G., Kumberova A., Croft N.M., et al. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 2001, 108:601-609.
10. Burke J.P., Watson R.W., Murphy M., et al. Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts. Br. J. Surg. 2009, 96:541-551.
11. Burke J.P., Watson R.W., Mulsow J.J., et al. Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts. Br. J. Surg. 2010, 97:892-901.
12. Li M.O., Wan Y.Y., Sanjabi S., et al. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146.
13. Rubtsov Y.P., Rudensky A.Y. TGF beta signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 2007, 7:443-453.
14. Dignass A.U., Podolsky D.K. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology 1993, 105:1323-1332.
15. Walsh M.F., Ampasala D.R., Hatfield J., et al. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am. J. Pathol. 2008, 173:385-399.
16. Nagata K., Saga S., Yamada K.M. A major collagen-binding protein of chick embryo fibroblasts is a novel heat shock protein. J. Cell Biol. 1986, 103:223-229.
17. Satoh M., Hirayoshi K., Yokota S., et al. Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized pro-collagen. J. Cell Biol. 1996, 133:469-483.
18. Nagata K., Hosokawa N. Regulation and function of collagen-specific molecular chaperone, HSP47. Cell Struct. Funct. 1996, 21:425-430.
19. Nakai A., Satoh M., Hirayoshi K., et al. Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J. Cell Biol. 1992, 117:903-914.
20. Ishida Y., Kubota H., Yamamoto A., et al. Type I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesis. Mol. Biol Cell. 2006, 17:2346-2355.
21. Masuda H., Fukumoto M., Hirayoshi K., et al. Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 1994, 94:2481-2488.
22. Yokota S., Kubota H., Matsuoka Y., et al. Prevalence of HSP47 antigen and autoantibodies to HSP47 in the sera of patients with mixed connective tissue disease. Biochem. Biophys. Res. Commun. 2003, 303:413-418.
23. Naitoh M., Hosokawa N., Kubota H., et al. Upregulation of HSP47 and collagen type III in the dermal fibrotic disease, Keloid. Biochem. Biophys. Res. Commun. 2001, 280:1316-1322.
24. Sato Y., Murase K., Kato J., et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 2008, 26:431-442.
25. Tamaki H., Nakamura H., Nishio A., et al. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006, 131:1110-1121.